FDA Authorizes IQOS to be Marketed as Modified Risk Tobacco Product
The U.S. Food and Drug Administration (FDA) has given Altria Group the ok to market its heat not burn device, IQOS, as a modified...
U.S. Senators Oppose Philip Morris International’s iQOS Application
Opposition is growing against Philip Morris International’s modified-risk application for iQOS. Ten U.S. senators–all Democrats–have sent a letter to Scott Gottlieb, the commissioner of...
FDA Authorizes Philip Morris USA to Sell IQOS in U.S.
Altria Group, Inc. has revealed that it has received authorization from the U.S. Food and Drug Administration (FDA) to sell its heat-not-burn device, IQOS,...
British American Tobacco Releases 2018 Harm Reduction Focus Report
Harm reduction has been a major initiative and focus of British American Tobacco (BAT) in recent years and 2018 was no different. With the...
Is the FDA on the Brink of True Harm Reduction?
In July, the FDA announced a new regulatory plan to focus on reducing nicotine levels in cigarettes, with the purpose of reducing cigarette addiction....
Philip Morris International’s Revenue and Stock Jumps Due to IQOS
Philip Morris International (PMI) can thank the emerging market of heat-not-burn for not only meeting but beating recent revenue estimates.
Earlier this year, the U.S....
